Cargando…
Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?
Pulmonary arterial hypertension (PAH) is an incurable disease characterized by an increase in pulmonary arterial pressure due to pathological changes to the pulmonary vascular bed. As a result, the right ventricle (RV) is subject to an increased afterload and undergoes multiple changes, including a...
Autores principales: | Loisel, Fanny, Provost, Bastien, Haddad, François, Guihaire, Julien, Amsallem, Myriam, Vrtovec, Bojan, Fadel, Elie, Uzan, Georges, Mercier, Olaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844533/ https://www.ncbi.nlm.nih.gov/pubmed/29480154 http://dx.doi.org/10.1177/2045893218755979 |
Ejemplares similares
-
Current Knowledge and Recent Advances of Right Ventricular Molecular Biology and Metabolism from Congenital Heart Disease to Chronic Pulmonary Hypertension
por: Guimaron, Samantha, et al.
Publicado: (2018) -
Echocardiographic evaluations of right ventriculo–arterial coupling in experimental and clinical pulmonary hypertension
por: Boulate, David, et al.
Publicado: (2019) -
Targeted proteomics of right heart adaptation to pulmonary arterial hypertension
por: Amsallem, Myriam, et al.
Publicado: (2021) -
Quantifying the Influence of Wedge Pressure, Age, and Heart Rate on the Systolic Thresholds for Detection of Pulmonary Hypertension
por: Amsallem, Myriam, et al.
Publicado: (2020) -
Pulsatile pulmonary artery pressure in a large animal model of chronic thromboembolic pulmonary hypertension: Similarities and differences with human data
por: Boulate, David, et al.
Publicado: (2022)